Lymphoma, T-Cell, Peripheral - 25 Studies Found
Not yet recruiting |
: 18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Peripheral T-cell Lymphoma : Lymphoma, T-Cell, Peripheral : 2017-02-09 : Device: 18F-FDG PET/ CT 18F-FDG PET/CT will be conducted before, during and after chemotherapy. Patients |
Not yet recruiting |
: Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Peripheral T-cell Lymphoma : Lymphoma, T-Cell, Peripheral : 2017-02-09 : Device: 18F-FDG PET/CT 18F-FDG PET/CT will be conducted before, during and after chemotherapy. Patients |
Recruiting |
: T-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma : Lymphoma, T-Cell, Peripheral : 2010-06-10 |
Recruiting |
: A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma : Lymphoma, T-Cell, Peripheral : 2005-09-13 : Drug: ONTAK (denileukin diftitox, DAB389 IL-2) Ontak + CHOP every 3 weeks. |
Completed |
: Intensive Chemo-immunotherapy as First Line Treatment in Adult Patients With Peripheral T- Cell Lymphoma : Lymphoma, T-Cell, Peripheral : 2012-08-30 :
|
Completed |
: A Retrospective Study of Clinical, Phenotypic and Genetic Factors of Peripheral T-Cell Lymphomas : Lymphoma, T-Cell, Peripheral : 2016-05-23 : Other: No Intervention |
Active, not recruiting |
: A Japanese Phase 1/2 Study to Assess the Efficacy, Safety and Pharmacokinetics of Romidepsin in Patients With Peripheral T-cell Lymphoma (PTCL) : Lymphoma, T-cell, Peripheral : 2011-10-18 : Drug: Romidepsin Intravenous dosing for 4 hours on Days 1, 8, and 15 of each 28-day cycle |
Not yet recruiting |
: Compared the Efficacy and Safety of CDOP Combined With Chidamide and CDOP in de Novo Peripheral T Cell Lymphoma Patients : Peripheral T Cell Lymphoma : 2016-11-03 :
|
Recruiting |
: Endostar Aggressive Treatment of Peripheral T-cell Lymphoma (PTCL) Phase II Clinical Study : Peripheral T-cell Lymphomas : 2015-07-26 :
|
Completed |
: Treatment of Peripheral T-cell Lymphoma : Peripheral T-cell Lymphoma : 2012-08-10 :
|